Ondřej Slabý

Candidate MicroRNA biomarkers of therapeutic response to sunitinib in metastatic renal cell carcinoma: A validation study in patients with extremely good and poor response

2018 | Lékařská fakulta v Plzni, 1. lékařská fakulta

Publikace